SHPT is a chronic kidney disease- (CKD-) mineral and bone disorder and is characterized by alterations in serum calcium, phosphate, intact parathyroid hormone (iPTH), vitamin D, and FGF23; bone abnormalities; and vascular calcification. The gene discussed is FGF23; the disease is chronic kidney disease.